⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,639.72
−0.31%
Nasdaq 100
29,093.04
+0.46%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$211.67
−0.25%
NYSE:TSM
$417.61
+1.28%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,001.48
−0.57%
Brent
$116.24
+2.97%
BTC
$81,658.15
+0.42%
ETH
$2,405.93
+0.83%
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,639.72
−0.31%
Nasdaq 100
29,093.04
+0.46%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$211.67
−0.25%
NYSE:TSM
$417.61
+1.28%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,001.48
−0.57%
Brent
$116.24
+2.97%
BTC
$81,658.15
+0.42%
ETH
$2,405.93
+0.83%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› NKTR
N
Nektar Therapeutics
NAS:NKTR
Healthcare
CBOEFTSE:MRUT
NASDAQ:NCX
$37.12
−3.96%
Live
In session · ≈
AED 136.32
· Market cap
$1.27B
· Next earnings
Thu 5 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
NKTR news
Headlines tagged to this company
SE
Nektar, Protagonist, Shattuck are Leerink top picks in emerging immunology
Seeking Alpha · 11 d ago
DO
Nektar Therapeutics Initiated at Neutral by UBS
Dow Jones Newswires · 11 d ago
DO
Nektar Therapeutics Price Target Announced at $130.00/Share by Leerink Partners
Dow Jones Newswires · 11 d ago
DO
Nektar Therapeutics Price Target Maintained With a $178.00/Share by BTIG
Dow Jones Newswires · 14 d ago
TR
BTIG reiterates Buy rating on Nektar Therapeutics, $178 price target
TradingView · 14 d ago
DO
Nektar Therapeutics Initiated at Market Perform by Raymond James
Dow Jones Newswires · 14 d ago
DO
Nektar Therapeutics Price Target Maintained With a $185.00/Share by HC Wainwright & Co.
Dow Jones Newswires · 21 d ago
TR
HC Wainwright & Co. reiterates Buy rating on Nektar Therapeutics, $185 price target
TradingView · 21 d ago
ST
NKTR Stock Eyes Worst Day In Over 3 Years On Rezpeg Data: William Blair Still Sees A Durability Edge
Stocktwits · 22 d ago
SE
Nektar drops after new mid-stage trial data for hair loss drug
Seeking Alpha · 22 d ago
DO
Nektar Stock Sinks Despite Promising Hair Loss Treatment Data — Barrons.com
Dow Jones Newswires · 22 d ago
QU
NKTR: REZPEG showed durable hair regrowth and strong safety in alopecia areata, with lasting off-drug effects
Quartr · 22 d ago
QU
NKTR: REZPEG showed durable hair regrowth and broad immune modulation, supporting its first-line potential
Quartr · 22 d ago
TR
Nektar presents durable Phase 2b rezpegaldesleukin data; Phase 3 ZENITH AA starts early 2027
TradingView · 22 d ago
QU
NKTR: Rezpegaldesleukin shows durable, deepening efficacy and safety in alopecia areata and atopic dermatitis
Quartr · 22 d ago
RE
Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
Reuters · 22 d ago
QU
NKTR: REZPEG rapidly improved clinical and molecular outcomes in moderate-to-severe atopic dermatitis
Quartr · 22 d ago
TR
Weekly Recap: Phase 3 ZENITH AD trials and $90M jury award
TradingView · 25 d ago
More news →
Nektar Therapeutics · News · TradingHolo